Cochrane Abstracts
Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Allogeneic Stem Cell Transplantation Versus Conventional Therapy for Advanced Primary Cutaneous T‐cell Lymphoma." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438603/all/Allogeneic_stem_cell_transplantation_versus_conventional_therapy_for_advanced_primary_cutaneous_T‐cell_lymphoma.
Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438603/all/Allogeneic_stem_cell_transplantation_versus_conventional_therapy_for_advanced_primary_cutaneous_T‐cell_lymphoma. Accessed March 20, 2025.
Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438603/all/Allogeneic_stem_cell_transplantation_versus_conventional_therapy_for_advanced_primary_cutaneous_T‐cell_lymphoma
Allogeneic Stem Cell Transplantation Versus Conventional Therapy for Advanced Primary Cutaneous T‐cell Lymphoma [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 March 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438603/all/Allogeneic_stem_cell_transplantation_versus_conventional_therapy_for_advanced_primary_cutaneous_T‐cell_lymphoma.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T‐cell lymphoma
ID - 438603
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438603/all/Allogeneic_stem_cell_transplantation_versus_conventional_therapy_for_advanced_primary_cutaneous_T‐cell_lymphoma
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
